Atea Pharmaceuticals Inc (AVIR) — Cash Flow Quality Index
Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Quality Index of -0.64x as of December 2021. Operating cash flow of $-75.42 Million is below net income of $117.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Atea Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Atea Pharmaceuticals Inc Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Atea Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Atea Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Atea Pharmaceuticals Inc (2021–2021)
Year-by-year earnings quality comparison for Atea Pharmaceuticals Inc. For live market cap and the full company financial profile, see AVIR market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.72x | $-87.00 Million | $121.19 Million | — |